Nath Bio-Genes (India) Share Price

    NSE
    226
    -0.45 (0.00%)
    NATHBIOGEN • 11 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    -9.38%

    3Y Annualised Return

    5.31%

    5Y Annualised Return

    -7.30%

    The current prices are delayed, login or Open Demat Account for live prices.

    Nath Bio-Genes (India) Stock Performance

    1W Return6.43
    1Y Return-8.09
    Today's Low221
    Prev. Close226.45
    Mkt Cap (Cr.)436.46
    1M Return12.64
    3Y Return22.79
    52-Week High256.01
    Open221.00
    PE Ratio10.31
    6M Return32.86
    Today's High233
    52-Week Low137.55
    Face Value10

    Nath Bio-Genes (India) Company background

    Founded in: 1993
    Managing director: Satish Kagliwal
    Nath BioGenes (India) Limited was originally incorporated in the name and style of Shivnath Farms Private Limited as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited and further changed from Shivnath Farms Limited to Nath BioGenes (India) Limited on March 05, 2001.The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing highquality seeds to Indian farmers. The Companys robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials. The Companys commitment to excellence is further demonstrated through its comprehensive extension programs designed to empower farmers. These initiatives include product awareness campaigns, crop demonstrations, agronomic input guidance, fertigation practices, and postharvest management training.As Nath BioGenes transitions from addressing food security to focusing on nutritional security, the Company is dedicated to bringing healthier seed varieties from farms to consumers plates. This strategic shift underscores the ongoing mission to support farmers and contribute to overall well being of the population through innovative agricultural solutions.Presently, the Company is engaged in the business of production, processing, and marketing of hybrid and GM seeds. The Company has a product into field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). In India, the company has nearly 16 business centres covering 131 territories connecting with over 2,000 distributors, all across the country. The company has been presently venturing to newer geographies outside the country, possessing similar agronomical conditions as India. all set to spread its wings in other parts of Asia, Africa the Middle East. The company has developed modern infrastructure facilities, biotech lab and seed technology lab. It has a wide dealers and distribution network of PAN India marketing distribution network which is manned by technically and commercially skilled marketing team. The Company produced several highly ranked cotton seeds in the country which have done well in the ICAR trials and stood the test of time with respect to various virus tolerance as well as improved yield in spite of weather fluctuations. It is the first seed company in Asia Pacific region to get ISO 9001 certificate. Its new launches Sanket and Daksh cotton seeds have been ranked among top 3 in most geographies and under various planting conditions. The consistent high rank achieved by companys new seeds gives reasonable confidence about it growing its cotton seeds portfolio faster than the industry. The strategy is to provide farmers with a wide range of varieties of cotton seeds suitable for diverse climatic conditions while maintaining yield superiority. The company has worked on derisking its business by having multiple growth drivers like paddy, vegetable seeds and plant nutrient in its portfolio. The company established a network of over 15,000 farmers growing seeds. It has been awarded with the prestigious Vasantrao Naik Prathisthan Award for its contribution for enhancing Agricultural Productivity amongst other rewards recognition.At present, the company has about 18 breeding and evaluation RD Stations in different agroclimatic conditions. It has more than 300 acres of land dedicated to research and development, across the nation. It has collaboration with reputed International and National Centres of Excellence (NRCPB, CIMMYT, IRRI, ICRISAT Etc.) The company has a team of handpicked plant breeders and bio technologists, located at key RD stations, across the country, guided by RD veterans. It undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 72 technically qualified organizers. The company assures that seeds of the highest quality reaches the processing centers by setting rigorous field standards and quality control checks throughout the seed production process. The company has elaborate seed processing facilities with 10 Processing Plants located in Maharashtra and Andhra Pradesh. It has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis. The seeds receivedfrom growers are processed to achieve quality standards which surpass those prescribed by the regulatory authorities. All the plants are equipped with precleaner, fine cleaner, grader, gravity separator, destoner, indented cylinder, treater, needle separator and packing machines which are fully automated. The company has independent facilities for ginning, delinting, drying, processing, treating, packing and storage of seeds. The seed processing quality is taken to the next level by ensuring improvements in seed viability and prolonging the shelf life of seeds. All the packing material has best environmental barriers characteristics to guarantee optimal storage conditions for the seed.The companys key function is to rigorously test products in various agroclimatic regions and compare the yield to benchmark products of competitors. The product undergoes a rigorous state gate screening process comprising six stages prior to commercial release. Seed Production and Disease Screening are an instrumental part of product development with testing spread across 40 locations, 8 centres and all agroclimatic zones of India. Besides, trials are conducted in three phases to thoroughly test the performance of products before recommending for a national launch. The three different phases of trials are MLT (Multi Location Trial), LST (Large scale Trial) and Demonstrations. For the Multilevel trials, the company have nearly eight stations each at a different agroclimatic zone divided across the length and breadth of the country.The Company launched two high performing new cotton hybrids seeds, Sanket and Daksh in 201920. NBIL undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 100 plus technically qualified organizers. Seed is produced in the states of Andhra Pradesh, Gujarat, Karnataka, Maharashtra, Rajasthan, Odisha, Uttar Pradesh, Madhya Pradesh, and Tamil Nadu which covers different agroclimatic zones of the country. The company assures that seeds of the highest quality reach its processing centres by setting rigorous field standards and quality control checks throughout the seed production process. A team of qualified production staff and quality personnel visit to monitor farms in order to ensure stringent controls. The foundation seed with highest genetic purity is sown in all crops.In 202122, the Company launched four new products in different segments of hybrid paddy including Dhoom, Dhadak and Dhadak Gold.In 202324, the Company further introduced two new organic fertilizers, WINALL granules and WINPRO GOLI, to the product basket by addressing the critical need for soil nutritional supplements. A Joint Venture with 90% stake holding as JV Nath BioGenes CA LLC, Uzbekistan, was incorporated registered in 2024.

    As of 11 Jul, 2025, Nath Bio-Genes (India) share price is ₹229.7. The stock opened at ₹221 and had closed at ₹226.4 the previous day. During today’s trading session, Nath Bio-Genes (India) share price moved between ₹221.00 and ₹233.00, with an average price for the day of ₹227.00. Over the last 52 weeks, the stock has recorded a low of ₹137.55 and a high of ₹256.01. In terms of performance, Nath Bio-Genes (India) share price has increased by 32.9% over the past six months and has declined by 9.38% over the last year.

    Read More
    Nath Bio-Genes (India) SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹62,03,291 (-4.56%)
    Daily SIP of 25,000 would have become 62,03,291 in 1 year with a gain of -2,96,708 (-4.56%)
    View details of Market Depth

    Nath Bio-Genes (India) Fundamental

    Market Cap (in crs)

    436.46

    Face Value

    10

    Turnover (in lacs)

    171.76

    Key Metrics

    Qtr Change %
    66.97% Gain from 52W Low
    50.6
    Dividend yield 1yr %
    Below industry Median
    0.9

    Nath Bio-Genes (India) Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Nath Bio-Genes (India) Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    283.7 Cr
    51.97 Cr
    36.87 Cr
    32.19 Cr
    243.88 Cr
    Nath Bio-Genes (India) Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
    369.45 Cr
    333.25 Cr
    301.92 Cr
    280.22 Cr
    138.28 Cr
    124.82 Cr
    Nath Bio-Genes (India) Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    35.22 Cr
    0.94 Cr
    2.65 Cr
    1.11 Cr
    33.35 Cr
    Nath Bio-Genes (India) Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
    38.6 Cr
    39.62 Cr
    35.01 Cr
    -67.39 Cr
    11.75 Cr
    9.2 Cr

    Nath Bio-Genes (India) Result Highlights

    • Nath Bio-Genes (India) Ltd reported a 16.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were up by 22.6% QoQ and - - YoY.

    • The net profit decreased 1.1% QoQ and - - YoY.

    • The earnings per share (EPS) of Nath Bio-Genes (India) Ltd stood at 1.9 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Nath Bio-Genes (India)

    Promoter
    45.6%
    Foreign Institutions
    0.2%
    Mutual Funds
    3.9%
    Domestic Institutions
    4%
    Public
    50.2%
    Promoter
    45.6%
    Foreign Institutions
    0.2%
    Mutual Funds
    4.4%
    Domestic Institutions
    4.4%
    Public
    49.8%
    Promoter
    45.6%
    Foreign Institutions
    0.2%
    Mutual Funds
    4.4%
    Domestic Institutions
    4.4%
    Public
    49.8%
    Promoter
    45.6%
    Foreign Institutions
    0.2%
    Mutual Funds
    4.4%
    Domestic Institutions
    4.4%
    Public
    49.8%
    Promoter
    45.6%
    Foreign Institutions
    0.3%
    Mutual Funds
    4.4%
    Domestic Institutions
    4.3%
    Public
    49.8%
    Promoter
    45.6%
    Foreign Institutions
    0.3%
    Mutual Funds
    4.4%
    Domestic Institutions
    4.4%
    Public
    49.7%

    Nath Bio-Genes (India) Technical Analysis

    Moving Averages Analysis
    226
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    226.80
    10Day EMA
    221.30
    12Day EMA
    219.50
    20Day EMA
    213.50
    26Day EMA
    209.80
    50Day EMA
    198.50
    100Day EMA
    188.20
    200Day EMA
    186.90
    5Day SMA
    228.70
    10Day SMA
    219.00
    20Day SMA
    211.60
    30Day SMA
    205.90
    50Day SMA
    195.30
    100Day SMA
    175.50
    150Day SMA
    177.60
    200Day SMA
    182.30
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    86041 Rs
    86041 Rs
    Week Rs
    103156 Rs
    158796 Rs
    Month Rs
    49018 Rs
    74393 Rs
    227.89
    Pivot
    Resistance
    First Resistance
    234.78
    Second Resistance
    239.89
    Third Resistance
    246.78
    Support
    First Support
    222.78
    Second support
    215.89
    Third Support
    210.78
    Relative Strength Index
    68.15
    Money Flow Index
    75.12
    MACD
    9.66
    MACD Signal
    8.03
    Average True Range
    8.96
    Average Directional Index
    38.77
    Rate of Change (21)
    11.60
    Rate of Change (125)
    28.61
    Name
    Holding Percent
    ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADUTYA BIRLA SUN LIFE PURE VALUE FUND
    3.88

    Nath Bio-Genes (India) Latest News

    11 JUL 2025 | Friday

    Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

    11 JUL 2025 | Friday

    Nath Bio-Genes (India) Ltd - 537291 - Unaudited Financial Results As On 30Th June 2025.

    04 JUL 2025 | Friday

    Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The 30Th June 2025

    View More

    Nath Bio-Genes (India) Share Price FAQs

    Nath Bio-Genes (India) share price is ₹226 in NSE and ₹225.7 in BSE as on 11/7/2025.

    Nath Bio-Genes (India) share price in the past 1-year return was -8.08. The Nath Bio-Genes (India) share hit a 1-year low of Rs. 137.55 and a 1-year high of Rs. 256.01.

    The market cap of Nath Bio-Genes (India) is Rs. 436.46 Cr. as of 11/7/2025.

    The PE ratios of Nath Bio-Genes (India) is 10.31 as of 11/7/2025.

    The PB ratios of Nath Bio-Genes (India) is 0.66 as of 11/7/2025

    The Mutual Fund Shareholding in Nath Bio-Genes (India) was 3.89% at the end of 11/7/2025.

    You can easily buy Nath Bio-Genes (India) shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Nath Bio-Genes (India) share price is ₹256.01 and ₹137.55 as of 11/7/2025.

    Please be aware that Nath Bio-Genes (India) stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.92
    -0.05 (-0.08%)
    135.28
    -1.85 (-1.35%)
    681.80
    -13.80 (-1.98%)
    2,558.70
    -22.30 (-0.86%)
    160.00
    -9.64 (-5.68%)
    381.65
    -3.05 (-0.79%)
    159.84
    -0.82 (-0.51%)
    263.35
    +0.50 (+0.19%)
    409.30
    -4.20 (-1.02%)
    396.85
    -3.05 (-0.76%)
    Top Gainers
    2,519.60
    +111.20 (+4.62%)
    1,835.20
    +25.00 (+1.38%)
    1,173.80
    +9.50 (+0.82%)
    2,220.60
    +16.80 (+0.76%)
    858.85
    +6.00 (+0.70%)
    Top Losers
    3,266.00
    -116.00 (-3.43%)
    3,073.20
    -89.20 (-2.82%)
    8,067.00
    -218.00 (-2.63%)
    258.30
    -6.75 (-2.55%)
    4,218.70
    -102.60 (-2.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -